XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statements of Change in Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Common Stock
Additional paid in capital
Accumulated Deficit
Accumulated other comprehensive income (loss)
Noncontrolling interest
Total
Balance at the beginning of period at Dec. 31, 2019   $ 1,784 $ (1,064) $ 41 $ 1 $ 762
Balance at the beginning of period (in shares) at Dec. 31, 2019 59.9          
Increase (Decrease) in Shareholders' Equity            
Common stock issued under employee stock purchase plan   2       2
Common stock issued under employee stock purchase plan (in shares) 0.2          
Equity classified stock-based compensation expense   4       4
Comprehensive (loss) income     (48) (63)   (111)
Balance at the end of period at Mar. 31, 2020   1,790 (1,112) (22) 1 657
Balance at the end of period (in shares) at Mar. 31, 2020 60.1          
Balance at the beginning of period at Dec. 31, 2019   1,784 (1,064) 41 1 762
Balance at the beginning of period (in shares) at Dec. 31, 2019 59.9          
Increase (Decrease) in Shareholders' Equity            
Comprehensive (loss) income           223
Balance at the end of period at Sep. 30, 2020   1,800 (723) (79)   998
Balance at the end of period (in shares) at Sep. 30, 2020 61.0          
Balance at the beginning of period at Mar. 31, 2020   1,790 (1,112) (22) 1 657
Balance at the beginning of period (in shares) at Mar. 31, 2020 60.1          
Increase (Decrease) in Shareholders' Equity            
Reclassification of liability classified stock-based compensation awards to equity classified   (2)       (2)
Equity- settled stock- based compensation recovery from disposal of discontinued operations   (1)       (1)
Common stock issued under employee stock purchase plan   1       1
Common stock issued under employee stock purchase plan (in shares) 0.2          
Equity classified stock-based compensation expense   6       6
Equity classified stock-based compensation expense (in shares) 0.4          
Dividends     (1)     (1)
Comprehensive (loss) income     306 (64)   242
Balance at the end of period at Jun. 30, 2020   1,794 (807) (86) 1 902
Balance at the end of period (in shares) at Jun. 30, 2020 60.7          
Increase (Decrease) in Shareholders' Equity            
Common stock issued under employee stock purchase plan   2       2
Common stock issued under employee stock purchase plan (in shares) 0.2          
Equity classified stock-based compensation expense   4       4
Equity classified stock-based compensation expense (in shares) 0.1          
Dividends     (1)     (1)
Comprehensive (loss) income     85 7   92
Other         (1) (1)
Balance at the end of period at Sep. 30, 2020   1,800 (723) (79)   998
Balance at the end of period (in shares) at Sep. 30, 2020 61.0          
Balance at the beginning of period at Dec. 31, 2020   1,818 (763) (120) 1 $ 936
Balance at the beginning of period (in shares) at Dec. 31, 2020 61.2         61.2
Increase (Decrease) in Shareholders' Equity            
Common stock issuance, net of transaction fees   380       $ 380
Underwritten stock offering (in shares) 10.0          
Common stock issued under employee stock purchase plan   2       2
Common stock issued under employee stock purchase plan (in shares) 0.1          
Equity classified stock-based compensation expense   7       7
Equity classified stock-based compensation expense (in shares) 0.4          
Comprehensive (loss) income     (84) 6   (78)
Balance at the end of period at Mar. 31, 2021   2,207 (847) (114) 1 1,247
Balance at the end of period (in shares) at Mar. 31, 2021 71.7          
Balance at the beginning of period at Dec. 31, 2020   1,818 (763) (120) 1 $ 936
Balance at the beginning of period (in shares) at Dec. 31, 2020 61.2         61.2
Increase (Decrease) in Shareholders' Equity            
Comprehensive (loss) income           $ (10)
Balance at the end of period at Sep. 30, 2021   2,224 (790) (105) 1 $ 1,330
Balance at the end of period (in shares) at Sep. 30, 2021 72.6         72.6
Balance at the beginning of period at Mar. 31, 2021   2,207 (847) (114) 1 $ 1,247
Balance at the beginning of period (in shares) at Mar. 31, 2021 71.7          
Increase (Decrease) in Shareholders' Equity            
Common stock issued under employee stock purchase plan   2       2
Common stock issued under employee stock purchase plan (in shares) 0.1          
Equity classified stock-based compensation expense   2       2
Equity classified stock-based compensation expense (in shares) 0.6          
Dividends     (1)     (1)
Comprehensive (loss) income     45 5   50
Balance at the end of period at Jun. 30, 2021   2,211 (803) (109) 1 1,300
Balance at the end of period (in shares) at Jun. 30, 2021 72.4          
Increase (Decrease) in Shareholders' Equity            
Common stock issued under employee stock purchase plan   2       2
Common stock issued under employee stock purchase plan (in shares) 0.1          
Equity classified stock-based compensation expense   11       11
Equity classified stock-based compensation expense (in shares) 0.1          
Dividends     (1)     (1)
Comprehensive (loss) income     14 4   18
Balance at the end of period at Sep. 30, 2021   $ 2,224 $ (790) $ (105) $ 1 $ 1,330
Balance at the end of period (in shares) at Sep. 30, 2021 72.6         72.6